Pharmaceutical Supply of Flumazenil Injection

The Defense Logistics Agency, under the Department of Defense, has awarded a subcontract for the supply and delivery of Flumazenil Injection, identified by NDC 00143-9783-10, as a commercial off-the-shelf pharmaceutical product. This procurement adheres strictly to federal standards for pharmaceutical acquisition and distribution, ensuring the item meets all regulatory and quality requirements for use in military and federal healthcare settings. The contract is classified under NAICS code 325412, which pertains to pharmaceutical and biological product manufacturing, indicating the supplier must be a qualified pharmaceutical producer compliant with federal manufacturing and labeling norms. Delivery of the product will be coordinated to meet operational needs without specifying a single place of performance, suggesting distribution may occur across multiple federal facilities as required. The contract, posted on June 24, 2026, does not include a solicitation number or set-aside provisions, indicating it was issued as a direct subcontract without competitive bidding restrictions. The primary focus is on consistent, reliable supply of a critical pharmaceutical agent, with full compliance to Department of Defense procurement protocols and logistical frameworks. Additional details can be accessed through the provided DIBBS link, which serves as the official record of the award and fulfillment tracking.